News

Video

Dietrich and Shiller on the Importance of Oncology Reflex Testing

Related Videos
Christos Kyriakopoulos, MD
5 KOLs are featured in this program
5 KOLs are featured in this program
Bhavana Pothuri, MD
Marwan G. Fakih, MD
Joyce O'Shaughnessy, MD
Joseph Maakaron, MD, assistant professor, medicine, Division of Hematology, Oncology, and Transplantation, the University of Minnesota Medical School
David M. O’Malley, MD
Mohamad Mohty, MD, PhD, professor, hematology, Sorbonne University, head, Clinical Hematology and Cellular Therapy Department, Saint-Antoine Hospital
Related Content
odronextamab for relapsed/refractory FL and DLBCL
June 28th 2024

CHMP Recommends Odronextamab for Relapsed/Refractory FL and DLBCL

Martin F. Dietrich, MD, PhD, medical oncologist, Cancer Care Centers of Brevard, The US Oncology Network, assistant professor, internal medicine, the University of Central Florida College of Medicine; Michelle Shiller, DO, cancer liaison physician, medical director, Genetics, assistant medical director, Baylor Scott & White Health in Dallas, medical director, Genomics and Molecular Pathology Services, PathGroup
June 27th 2024

Dietrich and Shiller Dive Into the Importance of Oncology Reflex Testing

Chiara Cremolini, MD
June 28th 2024

Do Tumor-Naive MRD Assays Have a Role in Resected CRC? Cremolini Weighs in

Mark Agulnik, MD, professor, clinical medicine, vice chair, faculty development, Department of Medicine, section chief, Sarcomas & Melanoma, Keck School of Medicine, the University of Southern California
June 24th 2024

Agulnik Highlights Key Updates in GIST Research and Management

Elisa Fontana, MD, PhD
June 27th 2024

Lunresertib Plus FOLFIRI Shows Safety, Elicits Responses in CCNE1+ or FBXW7+ Advanced GI Tumors

Jeffrey Meyerhardt, MD, MPH, FASCO
June 27th 2024

Adding Celecoxib to Adjuvant Chemotherapy Offers DFS, OS Benefit in PIK3CA-Mutated Stage III Colon Cancer